Call Options

21 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$22.3 - $36.29 $111,500 - $181,450
-5,000 Reduced 80.65%
1,200 $27,000
Q2 2024

Aug 14, 2024

BUY
$16.07 - $31.84 $99,634 - $197,408
6,200 New
6,200 $179,000
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $17,264 - $23,600
-800 Reduced 9.2%
7,900 $213,000
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $95,460 - $147,889
-3,700 Reduced 29.84%
8,700 $257,000
Q2 2023

Aug 14, 2023

SELL
$20.94 - $38.01 $3.28 Million - $5.96 Million
-156,800 Reduced 92.67%
12,400 $443,000
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $3.21 Million - $4.73 Million
140,000 Added 479.45%
169,200 $3.97 Million
Q4 2022

Feb 14, 2023

SELL
$25.44 - $59.78 $608,016 - $1.43 Million
-23,900 Reduced 45.01%
29,200 $794,000
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $3.88 Million - $5.42 Million
-88,800 Reduced 62.58%
53,100 $2.86 Million
Q2 2022

Aug 08, 2022

BUY
$28.82 - $77.35 $3.52 Million - $9.46 Million
122,300 Added 623.98%
141,900 $5.72 Million
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $796,125 - $1.66 Million
-16,500 Reduced 45.71%
19,600 $1.3 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $141,936 - $192,688
1,600 Added 4.64%
36,100 $3.61 Million
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $483,973 - $647,632
-4,900 Reduced 12.44%
34,500 $4.31 Million
Q2 2021

Aug 16, 2021

SELL
$109.77 - $165.68 $1.81 Million - $2.73 Million
-16,500 Reduced 29.52%
39,400 $4.89 Million
Q1 2021

May 17, 2021

BUY
$127.04 - $179.1 $5.39 Million - $7.59 Million
42,400 Added 314.07%
55,900 $8.53 Million
Q4 2020

Feb 16, 2021

SELL
$99.96 - $135.93 $1.36 Million - $1.85 Million
-13,600 Reduced 50.18%
13,500 $1.74 Million
Q3 2020

Nov 16, 2020

BUY
$80.32 - $111.8 $1.37 Million - $1.91 Million
17,100 Added 171.0%
27,100 $3.03 Million
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $308,499 - $497,250
5,100 Added 104.08%
10,000 $811,000
Q1 2020

May 15, 2020

SELL
$59.04 - $88.81 $1.89 Million - $2.84 Million
-32,000 Reduced 86.72%
4,900 $341,000
Q4 2019

Feb 14, 2020

BUY
$59.49 - $82.78 $1.8 Million - $2.51 Million
30,300 Added 459.09%
36,900 $2.88 Million
Q3 2019

Nov 14, 2019

BUY
$62.59 - $110.3 $43,813 - $77,210
700 Added 11.86%
6,600 $421,000
Q2 2019

Aug 14, 2019

BUY
$63.94 - $91.11 $377,246 - $537,549
5,900 New
5,900 $509,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.